المؤلفون: Vidal, J, Bellosillo, B, Santos Vivas, C, García-Alfonso, P, Carrato, A, Cano, M T, García-Carbonero, R, Élez, E, Losa, F, Massutí, B, Valladares-Ayerbes, M, Viéitez, J M, Manzano, J L, Azuara, D, Gallego, J, Pairet, S, Capellá, G, Salazar, R, Tabernero, J, Aranda, E, Montagut, C

مصطلحات موضوعية: NGS, RAS mutations, anti-EGFR, colorectal cancer, mutant allele fraction, quadruple wild-type, Adult, Antineoplastic Combined Chemotherapy Protocols, Cetuximab, Class I Phosphatidylinositol 3-Kinases, Colorectal Neoplasms, DNA Mutational Analysis, Disease-Free Survival, ErbB Receptors, Female, GTP Phosphohydrolases, Germany, High-Throughput Nucleotide Sequencing, Humans, Male, Membrane Proteins, Middle Aged, Mutation, Neoplasm Metastasis, Protein Kinase Inhibitors, Proto-Oncogene Proteins B-raf, Proto-Oncogene Proteins p21(ras), Treatment Outcome

العلاقة: http://hdl.handle.net/10668/13472Test; http://www.annalsofoncology.org/article/S0923753419310853/pdfTest

الإتاحة: https://doi.org/10.1093/annonc/mdz005Test
http://hdl.handle.net/10668/13472Test
http://www.annalsofoncology.org/article/S0923753419310853/pdfTest

المؤلفون: Dalgleish, AG, Stebbing, J, Adamson, DJA, Arif, SS, Bidoli, P, Chang, D, Cheeseman, S, Diaz-Beveridge, R, Fernandez-Martos, C, Glynne-Jones, R, Granetto, C, Massuti, B, McAdam, K, McDermott, R, Munoz Martin, AJ, Papamichael, D, Pazo-Cid, R, Vieitez, JM, Zaniboni, A, Carroll, KJ, Wagle, S, Gaya, A, Mudan, SS

المساهمون: Action Against Cancer

المصدر: 796 ; 789

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Oncology, pancreatic cancer, Mycobacterium obuense, phase II, advanced pancreatic ductal adenocarcinoma, immunotherapy, gemcitabine, IMM-101, immunomodulator, TRIAL, SURVIVAL, ADENOCARCINOMA, GUIDELINES, FOLFIRINOX, SAFETY, Aged, 80 and over, Antimetabolites, Antineoplastic, Biomarkers, Tumor, Cancer Vaccines, Carcinoma, Pancreatic Ductal, Combined Modality Therapy, Deoxycytidine, Disease-Free Survival, Europe

العلاقة: British Journal of Cancer; http://hdl.handle.net/10044/1/48908Test; https://dx.doi.org/10.1038/bjc.2016.271Test; 092015-02

الإتاحة: https://doi.org/10.1038/bjc.2016.271Test
http://hdl.handle.net/10044/1/48908Test

المؤلفون: Rosell, R, Dafni, U, Felip, E, Curioni-Fontecedro, A, Gautschi, O, Peters, S, Massutí, B, Palmero, R, Aix, SP, Carcereny, E, Früh, M, Pless, M, Popat, S, Kotsakis, A, Cuffe, S, Bidoli, P, Favaretto, A, Froesch, P, Reguart, N, Puente, J, Coate, L, Barlesi, F, Rauch, D, Thomas, M, Camps, C, Gómez-Codina, J, Majem, M, Porta, R, Shah, R, Hanrahan, E, Kammler, R, Ruepp, B, Rabaglio, M, Kassapian, M, Karachaliou, N, Tam, R, Shames, DS, Molina-Vila, MA, Stahel, RA, BELIEF collaborative group

المساهمون: Popat, Sanjay, Marsden

مصطلحات موضوعية: BELIEF collaborative group, Humans, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Disease-Free Survival, Mutation, International Cooperation, Aged, Middle Aged, Female, Male, Intention to Treat Analysis, Response Evaluation Criteria in Solid Tumors, ErbB Receptors, Bevacizumab, Erlotinib Hydrochloride, Proof of Concept Study

وصف الملف: Print-Electronic; 444; image/png

العلاقة: The Lancet. Respiratory medicine, 2017, 5 (5), pp. 435 - 444; https://repository.icr.ac.uk/handle/internal/1190Test

الإتاحة: https://doi.org/10.1016/s2213-2600Test(17)30129-7
https://repository.icr.ac.uk/handle/internal/1190Test

المؤلفون: Rosell, R., Dafni, U., Felip, E., Curioni-Fontecedro, A., Gautschi, O., Peters, S., Massutí, B., Palmero, R., Aix, S.P., Carcereny, E., Früh, M., Pless, M., Popat, S., Kotsakis, A., Cuffe, S., Bidoli, P., Favaretto, A., Froesch, P., Reguart, N., Puente, J., Coate, L., Barlesi, F., Rauch, D., Thomas, M., Camps, C., Gómez-Codina, J., Majem, M., Porta, R., Shah, R., Hanrahan, E., Kammler, R., Ruepp, B., Rabaglio, M., Kassapian, M., Karachaliou, N., Tam, R., Shames, D.S., Molina-Vila, M.A., Stahel, R.A.

المساهمون: BELIEF collaborative group

المصدر: The Lancet. Respiratory medicine, vol. 5, no. 5, pp. 435-444

مصطلحات موضوعية: Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Bevacizumab/administration & dosage, Carcinoma, Non-Small-Cell Lung/drug therapy, Non-Small-Cell Lung/genetics, Disease-Free Survival, Erlotinib Hydrochloride/administration & dosage, Female, Humans, Intention to Treat Analysis, International Cooperation, Lung Neoplasms/drug therapy, Lung Neoplasms/genetics, Male, Middle Aged, Mutation, Proof of Concept Study, Receptor, Epidermal Growth Factor/genetics, Response Evaluation Criteria in Solid Tumors

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28408243; info:eu-repo/semantics/altIdentifier/eissn/2213-2619; https://serval.unil.ch/notice/serval:BIB_D6307005064DTest; urn:issn:2213-2600

الإتاحة: https://doi.org/10.1016/S2213-2600Test(17)30129-7
https://serval.unil.ch/notice/serval:BIB_D6307005064DTest

المؤلفون: Niki Karachaliou, Zoi Tsourti, Bartomeu Massuti, Santiago Ponce Aix, Martin Früh, Miklos Pless, Paolo Bidoli, Núria Jordana-Ariza, Ariadna Balada-Bel, H. Roschitzki-Voser, Enriqueta Felip, Solange Peters, Mónica Garzón-Ibáñez, Roswitha Kammler, Ramon Palmero, Sinead Cuffe, Clara Mayo-de-las-Casas, Rafael Rosell, Sanjay Popat, Enric Carcereny, M.A. Molina-Vila, Oliver Gautschi, Beatriz García-Peláez, Rolf A. Stahel, Urania Dafni, Alessandra Curioni Fontecedro

المساهمون: Molina-Vila, M, Stahel, R, Dafni, U, Jordana-Ariza, N, Balada-Bel, A, Garzón-Ibáñez, M, García-Peláez, B, Mayo-de-Las-Casas, C, Felip, E, Fontecedro, A, Gautschi, O, Peters, S, Massutí, B, Palmero, R, Aix, S, Carcereny, E, Früh, M, Pless, M, Popat, S, Cuffe, S, Bidoli, P, Kammler, R, Roschitzki-Voser, H, Tsourti, Z, Karachaliou, N, Rosell, R, University of Zurich, Stahel, Rolf A

المصدر: Journal of Thoracic Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Universidad de Alicante (UA)
JOURNAL OF THORACIC ONCOLOGY
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-IGTP: Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

مصطلحات موضوعية: EGFR mutations in blood, NSCLC, Survival, cfDNA, 0301 basic medicine, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Lung Neoplasms, genetic structures, Survival, Bevacizumab, EGFR, 610 Medicine & health, NSCLC, Gastroenterology, Disease-Free Survival, 03 medical and health sciences, Exon, 0302 clinical medicine, Internal medicine, medicine, Humans, In patient, cfDNA, neoplasms, Protein Kinase Inhibitors, business.industry, EGFR mutations in blood, DNA, Confidence interval, respiratory tract diseases, ErbB Receptors, 030104 developmental biology, Real-time polymerase chain reaction, Oncology, Circulating free DNA, Egfr mutation, 2740 Pulmonary and Respiratory Medicine, 030220 oncology & carcinogenesis, Mutation, 10032 Clinic for Oncology and Hematology, 2730 Oncology, Erlotinib, Neoplasm Recurrence, Local, business, Cell-Free Nucleic Acids, medicine.drug

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::994673a7e864203d23813318e7ec156aTest
http://hdl.handle.net/10281/260723Test

المؤلفون: Barbara Ruepp, Paolo Bidoli, Margarita Majem, Niki Karachaliou, Martin Früh, David S. Shames, Enriqueta Felip, Rachel Tam, Oliver Gautschi, Roswitha Kammler, Patrizia Froesch, Javier Puente, Solange Peters, José Gómez-Codina, Rolf A. Stahel, Linda Coate, Rut Porta, Emer Hanrahan, Alessandra Curioni-Fontecedro, Urania Dafni, Ramon Palmero, Carlos Camps, Enric Carcereny, Rafael Rosell, Daniel Rauch, Sanjay Popat, Miguel Angel Molina-Vila, Michael Thomas, Manuela Rabaglio, Sinead Cuffe, M. Kassapian, Adolfo Favaretto, Riyaz Shah, Fabrice Barlesi, Miklos Pless, Bartomeu Massuti, Noemi Reguart, Athanasios Kotsakis, Santiago Ponce Aix

المساهمون: Rosell, R, Dafni, U, Felip, E, Curioni-Fontecedro, A, Gautschi, O, Peters, S, Massutí, B, Palmero, R, Aix, S, Carcereny, E, Früh, M, Pless, M, Popat, S, Kotsakis, A, Cuffe, S, Bidoli, P, Favaretto, A, Froesch, P, Reguart, N, Puente, J, Coate, L, Barlesi, F, Rauch, D, Thomas, M, Camps, C, Gómez-Codina, J, Majem, M, Porta, R, Shah, R, Hanrahan, E, Kammler, R, Ruepp, B, Rabaglio, M, Kassapian, M, Karachaliou, N, Tam, R, Shames, D, Molina-Vila, M, Stahel, R

المصدر: Lancet Respiratory Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Male, medicine.medical_specialty, Lung Neoplasms, Bevacizumab, International Cooperation, Population, Proof of Concept Study, Disease-Free Survival, 03 medical and health sciences, T790M, Erlotinib Hydrochloride, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Medicine, Humans, 610 Medicine & health, education, Lung cancer, Response Evaluation Criteria in Solid Tumors, Aged, education.field_of_study, EGFR, NSCLC, business.industry, Middle Aged, Resistance mutation, medicine.disease, respiratory tract diseases, Surgery, Intention to Treat Analysis, ErbB Receptors, 030104 developmental biology, 030220 oncology & carcinogenesis, Mutation, Female, Erlotinib, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc716fb89940576072d11e1db6e24006Test
https://pubmed.ncbi.nlm.nih.gov/30636675Test